findmyKOL
Clinical trialNCT05000216TerminatedPhase 2Interventional

COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders

SponsorNational Institute of Allergy and Infectious Diseases (NIAID)Enrollment258Juvenile Dermatomyositis (JDM)Juvenile Idiopathic Arthritis (JIA)Multiple Sclerosis (MS)Pediatric SLEPediatric-Onset Multiple Sclerosis (POMS)Pemphigus Vulgaris+3 more conditions
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

29 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Ucla Medical Center: Division of Rheumatology

    Los Angeles, California, United States

  • Yale University School of Medicine: Rheumatology, Allergy & Immunology

    New Haven, Connecticut, United States

  • the Emory Clinic: Division of Rheumatology

    Atlanta, Georgia, United States

  • Indiana University Medical Center, Riley Hospital for Children

    Indianapolis, Indiana, United States

  • Boston Children'S Hospital: Department of Pediatrics, Rheumatology Program

    Boston, Massachusetts, United States

  • Brigham & Women'S Hospital: Department of Medicine, Rheumatology, Immunology

    Boston, Massachusetts, United States

  • Massachusetts General Hospital: Rheumatology, Allergy and Immunology, Center for Immunology and Inflammatory Diseases

    Boston, Massachusetts, United States

  • University of Michigan Health System: Department of Internal Medicine, Division of Rheumatology

    Ann Arbor, Michigan, United States

  • Washington University School of Medicine in St. Louis: Division of Rheumatology

    St Louis, Missouri, United States

  • Feinstein Institute for Medical Research

    Manhasset, New York, United States

  • Feinstein Institute for Medical Research: Center for Autoimmune and Musculoskeletal Diseases

    Manhasset, New York, United States

  • Columbia University Irving Medical Center: Department of Neurology, Multiple Sclerosis Center

    New York, New York, United States

  • Hospital for Special Surgery

    New York, New York, United States

  • New York University Langone Medical Center: Department of Medicine, Division of Rheumatology

    New York, New York, United States

  • University of Rochester Medical Center

    Rochester, New York, United States

  • Stony Brook University Hospital

    Stony Brook, New York, United States

  • University of North Carolina Children'S Hospital

    Chapel Hill, North Carolina, United States

  • Duke University Medical Center: Division of Rheumatology and Immunology

    Durham, North Carolina, United States

  • Cleveland Clinic

    Cleveland, Ohio, United States

  • Nationwide Children'S Hopspital

    Columbus, Ohio, United States

  • Oklahoma Children'S Hospital-Pediatrics Specialties Clinic

    Oklahoma City, Oklahoma, United States

  • Oklahoma Medical Research Foundation: Arthritis and Clinical Immunology Research Program

    Oklahoma City, Oklahoma, United States

  • Temple Health: Rheumatology

    Philadelphia, Pennsylvania, United States

  • University of Pennsylvania Perelman Center for Advanced Medicine

    Philadelphia, Pennsylvania, United States

  • Medical University of South Carolina, Nexus Research Center

    Charleston, South Carolina, United States

  • Medical University of South Carolina, Shawn Jenkins Children'S Hospital

    Charleston, South Carolina, United States

  • Ut Southwestern (peds)

    Dallas, Texas, United States

  • University of Texas Houston Medical School: Division of Rheumatology and Clinical Immunogenetics

    Houston, Texas, United States

  • Benaroya Research Institute at Virginia Mason: Internal Medicine

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
13 Aug 2021
Primary completion
22 Jun 2023
Completion
28 Mar 2024
Last update posted
10 Jun 2026
Registered enrollment
258
Registry id
NCT05000216

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.